Taken together, our findings (see Fig. 8 for an overview of insulin’s cardiovascular effects) identify admission cortisol and glucose levels as robust, rapidly available biomarkers for early risk stratification in infarction-related cardiogenic shock. The gene discussed is INS; the disease is infarction.